Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1994-5-6
|
pubmed:abstractText |
The cytotoxic T cell response of peripheral blood mononuclear cells (PBMC) to in vitro stimulation with human T cell leukemia virus type I (HTLV-I) was compared among HTLV-I-infected individuals with various clinical conditions. Induction of HTLV-I-specific cytotoxic T lymphocytes (CTL) was observed in 57% of asymptomatic HTLV-I carriers, 86% of patients with HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) or other HTLV-I-related inflammatory diseases, and 18% of adult T cell leukemia (ATL) patients. HTLV-I p40tax, one of the major CTL target antigens, has an epitope strongly associated with HLA-A2. HTLV-I p40tax-specific CTL were frequently induced from HLA-A2-positive donors with HTLV-I-related inflammatory diseases regardless of neurological symptoms, but not from all the HLA-A2-positive HTLV-I-infected individuals tested. Leukemic cells of an ATL patient with HLA-A2, whose PBMC did not show an HTLV-I-specific CTL response, could be lyzed by p40tax-specific CTL derived from an HAM/TSP patient. This indicates that i) the presence of a certain HLA presenting CTL epitopes is not the sole determinant of the individual CTL response to HTLV-I, ii) HTLV-I-specific CTL act as potential effectors of anti-tumor surveillance in vivo. The role of HTLV-I-specific CTL, however, may be limited by another in vivo mechanism suppressing the expression of HTLV-I antigens. This suppression, presumably mediated by a plasma factor and commonly observed in HTLV-I-infected individuals, could be one reason for the persistence of HTLV-I-infection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0887-6924
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S54-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8152305-Antigens, CD4,
pubmed-meshheading:8152305-Antigens, CD8,
pubmed-meshheading:8152305-Base Sequence,
pubmed-meshheading:8152305-HLA-A2 Antigen,
pubmed-meshheading:8152305-HTLV-I Infections,
pubmed-meshheading:8152305-Human T-lymphotropic virus 1,
pubmed-meshheading:8152305-Humans,
pubmed-meshheading:8152305-Leukemia, T-Cell,
pubmed-meshheading:8152305-Molecular Sequence Data,
pubmed-meshheading:8152305-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:8152305-Virus Replication
|
pubmed:year |
1994
|
pubmed:articleTitle |
Cytotoxic T cell response and expression of the target antigen in HTLV-I infection.
|
pubmed:affiliation |
Department of Biodefence and Medical Virology, Kumamoto University School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|